the monitoring of the use of anabolic hormones in patients with progressive duchenne 's muscular dystrophy was shown to be possible with the help of the clinical analysis of the patients ' motor possibilities , electroneuromyographic examination and determination of the time-course of the urinary excretion of catecholamines and dopa .
C0007412
catecholamines
C0013023
dopa